Unknown

Dataset Information

0

USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway

ABSTRACT:

SUBMITTER: Li A 

PROVIDER: S-EPMC10965993 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Proteomics USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway
2024-02-20 | PXD049717 |
Unknown ZCCHC12 promotes the progression of osteosarcoma via PI3K/AKT pathway.
| S-EPMC9550259 | biostudies-literature
Unknown PLEK2 promotes osteosarcoma tumorigenesis and metastasis by activating the PI3K/AKT signaling pathway.
| S-EPMC8161470 | biostudies-literature
Unknown SLC25A32 promotes malignant progression of glioblastoma by activating PI3K-AKT signaling pathway.
| S-EPMC10294537 | biostudies-literature
Unknown CDKL3 promotes osteosarcoma progression by activating Akt/PKB.
| S-EPMC7119369 | biostudies-literature
Unknown EPHA2 promotes triple-negative breast cancer progression by suppressing pyroptosis via the AKT/PI3K/mTOR pathway.
| S-EPMC12411449 | biostudies-literature
Unknown Correction: CDKL3 promotes osteosarcoma progression by activating Akt/PKB.
| S-EPMC9603691 | biostudies-literature
Unknown VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway.
| S-EPMC9102726 | biostudies-literature
Unknown ESM1 promotes angiogenesis in colorectal cancer by activating PI3K/Akt/mTOR pathway, thus accelerating tumor progression.
| S-EPMC10188330 | biostudies-literature
Unknown NOTCH3 promotes malignant progression of bladder cancer by directly regulating SPP1 and activating PI3K/AKT pathway.
| S-EPMC11574029 | biostudies-literature